Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing
September 16, 2022 at 11:35 AM EDT
A Villanova-based biotech startup focus on heart disease gets a new CEO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|